The ACCESS Consortium, a five-strong international work-sharing initiative aimed at accelerating drug approvals, has “resurrected” its clinical trials working group under the leadership of the UK’s Medicines and Healthcare products Regulatory Agency.
ACCESS Consortium Exploring Clinical Trials Collaboration & Reliance, Says UK MHRA
The UK’s drug regulator, the MHRA, is exploring new opportunities to work closer with its counterparts from Australia, Canada, Singapore and Switzerland under the ACCESS Consortium group, with a focus on pre-submission scientific advice.
